Prof. Torsten Haferlach, Head of MLL Munich Leukemia Laboratory, will discuss how their laboratory has implemented NGS technology for sequencing targeted gene panels.
Join in to hear about
· Application of NGS to molecular pathology assessment of hematological malignancies
· Integrated process for data analysis and reporting results
Join the live webinar event and participate in the Q&A session!